February 15, 2023
2:00 - 3:00 p.m. ET
The U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) serves as the gateway through which many of the diagnostic products underpinning personalized medicine enter the United States market. During this conversation with representatives of the Alliance for a Stronger FDA, CDRH Associate Director for Scientific and Regulatory Programs Dr. Elizabeth Hillebrenner will discuss FDA’s role in diagnostics regulation.
PMC members shape and advance the future of personalized medicine.